UNH vs ABT
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Abbott Laboratories, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | ABT |
|---|---|---|
| Price | $396.59 | $116.13 |
| Market cap | $355.98B | $200.95B |
| P/E ratio | 25.6 | 37.7 |
| ROE | 14.15% | 10.58% |
| Profit margin | 3.14% | 11.65% |
| Revenue growth | 0.40% | 13.00% |
| Dividend yield | 2.33% | 2.16% |
| Beta | 0.63 | 0.58 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs ABT in plain English
- UNH is the bigger company — about 1.8× the market cap of ABT.
- UNH is cheaper on earnings (P/E 25.6 vs 37.7).
- UNH earns a higher return on equity (14% vs 11%).
- ABT is growing revenue faster (13% vs 0%).
- UNH has the higher dividend yield (2.33% vs 2.16%).
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
ABT return calculator
See what $1,000 in Abbott Laboratories would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.